We are live on ! Find out more
MXCT icon

MaxCyte

115 hedge funds and large institutions have $208M invested in MaxCyte in 2025 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 40 increasing their positions, 44 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.82% more ownership

Funds ownership: 68.83%71.66% (+2.8%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

9% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 44

3% less funds holding

Funds holding: 119115 (-4)

21% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 14

31% less capital invested

Capital invested by funds: $303M → $208M (-$94.9M)

Holders
115
Holders Change
-4
Holders Change %
-3.36%
% of All Funds
1.54%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
11
Increased
40
Reduced
44
Closed
14
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
-$56K
Name Holding Trade Value Shares
Change
Change in
Stake
BIG
126
Brooklyn Investment Group
New York
-$1.7K -409 Closed
Creative Planning
127
Creative Planning
Kansas
-$1.45K -348 Closed
CIAM
128
Caitong International Asset Management
Hong Kong
-$678 -163 Closed

MXCT Hedge Fund Activity: Q1 2025 in Review

115 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q1 2025, worth a combined $208M — down 31% from $303M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of MXCT and 11 opened new positions — a net loss of 3 holders — while 44 trimmed existing stakes and 40 added.

The largest buyer was Mirabella Financial Services, adding an estimated $14.6M. The largest seller was Millennium Management, cutting an estimated $5.37M.

  • 115 institutional investors held MaxCyte (MXCT) as of Q1 2025, down from 119 in Q4 2024.
  • Funds reported $208M of MaxCyte stock for Q1 2025, down 31% quarter-over-quarter.
  • 11 funds opened new MaxCyte positions in Q1 2025 and 14 closed out, a net change of -3 holders.
  • The largest MaxCyte buyer in Q1 2025 was Mirabella Financial Services, an estimated $14.6M added.
  • The largest MaxCyte seller in Q1 2025 was Millennium Management, an estimated $5.37M sold.

Based on aggregated 13F filings for Q1 2025.